Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02315534
Title A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Laura and Isaac Perlmutter Cancer Center New York New York 10016 United States Details
University of Calgary Calgary Alberta Canada Details
Princess Margaret Cancer Centre Toronto Ontario Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field